Delfi Diagnostics Funding & Investors
Delfi Diagnostics detects cancer early, when it is most curable, using high-precision non-invasive blood tests. It uses artificial intelligence and genome sequencing to detect unique patterns of DNA fragmentation in the blood of patients. The company was founded in 2019 and is based in Baltimore, Maryland.
delfidiagnostics.comTotal Amount Raised: $330,500,000
Delfi Diagnostics Funding Rounds
Series B
$225,000,000
Series B Investors
DFJ Growth ManagementSamsara BiocapitalEli LillyAV8 VenturesPoint72Menlo VenturesIllumina VenturesOpen Field CapitalWindham Venture PartnersT. Rowe PriceRock Springs CapitalOrbiMed AdvisorsPoint Field PartnersForesite CapitalCowen Healthcare InvestmentsBrown AdvisoryOUP ManagementNorthpond VenturesPTX CapitalINITIATESeries A
$100,000,000
Series A Investors
OrbiMed AdvisorsAV8 VenturesWindham Venture PartnersRock Springs CapitalMenlo VenturesSamsara BiocapitalNorthpond VenturesT. Rowe PriceOUP ManagementCowen Healthcare InvestmentsForesite CapitalIllumina VenturesSeed
$5,500,000
Seed Investors
Menlo VenturesIllumina VenturesAV8 VenturesWindham Venture PartnersSamsara Biocapital
Funding info provided by Diffbot.